# JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD (JXUD)

**Source:** https://fundology.uk/fund/jxud · ISIN IE000QC2YB58 · Data: TradingView (LSE closes and returns, delayed), issuer documents, ONS CPIH, FCA FIRDS

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 30/09/2026, JXUD (Global ex US Research Enhanced Index Equity Active UCITS ETF - USD, ISIN IE000QC2YB58) closed at $25.02 on the London Stock Exchange. Its ongoing charge is 0.31% a year (about £31 on £10,000).

## Summary

JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD is an exchange-traded fund (ETF) from JPMorgan, launched in 2026. It tracks the No Underlying Index. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.31% a year — about £31 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

Latest close: **$25.02** (30/09/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | JXUD |
| ISIN | IE000QC2YB58 |
| Category | Global shares |
| Type | ETF |
| Provider | JPMorgan |
| Income | Distributing |
| Ongoing charge | 0.31% a year (£31 per £10,000) |
| Fund size | £373k |
| Launched | 2026 |
| Domicile | Ireland |

## Charges compared with similar funds

Ongoing charge of JPMorgan ETFs (Ireland) ICAV - Global ex US Research Enhanced Index Equity Active UCITS ETF - USD 0.31% a year, as of 01/10/2026: 87 of the 211 other global share funds charge more, 4 the same and 120 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.31%** per year
- ISA eligible: yes
- SIPP eligible: yes

## Top holdings

Largest positions (as of 30/09/2026):

| Holding | Weight |
|---|---|
| ASML Holding NV /Eur/ | 3.38% |
| Siemens Ag-Reg /Eur/ | 1.55% |
| Astrazeneca Plc /Gbp/ | 1.48% |
| HSBC Holdings Plc /Gbp/ | 1.31% |
| Allianz SE Registered /Eur/ | 1.30% |
| Banco Santander SA /Eur/ | 1.27% |
| Shell Plc-New /Gbp/ | 1.22% |
| Roche Holding AG /Chf/ | 1.15% |
| Safran SA /Eur/ | 1.15% |
| Royal Bank of Canada /Cad/ | 1.12% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.

### By sector

As published by JPMorgan, as of 30/09/2026.

| Sector | Weight |
|---|---|
| Banks | 19.9% |
| Others | 15.4% |
| Industrial Cyclicals | 12.2% |
| Basic Industries | 9.3% |
| Pharm/MedTech | 7.7% |
| Technology - Semi & Hardware | 7.7% |
| Insurance | 6.5% |
| Energy | 5.1% |
| Other sectors | 16.2% |

### By country

Added up from the holdings JPMorgan publishes, as of 30/09/2026.

| Country | Weight |
|---|---|
| Japan | 22.3% |
| United Kingdom | 13.7% |
| Canada | 12.1% |
| France | 9.7% |
| Germany | 9.4% |
| Netherlands | 6.7% |
| Switzerland | 6.2% |
| Australia | 5.8% |
| Other countries | 14.1% |

### By type of asset

Added up from the holdings JPMorgan publishes, as of 30/09/2026.

| Type of asset | Weight |
|---|---|
| Equity | 99.6% |
| Cash and money market | 0.4% |

All 286 holdings: https://fundology.uk/fund/jxud/holdings

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.